BackSarepta Therapeutics Overview

Sarepta Therapeutics Profit Margin

Profitability ratio analysis for SRPT.

Quarterly Profit Margin

45.29%
↑ 175.38% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-2.94%
↑ 73.52% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin